🔎 Trials Near Me

Home › Myelodysplastic Syndromes › Illinois › Chicago

Pag-aaral pangklinika para sa Myelodysplastic Syndromes sa Chicago, IL

Isang pag-aaral para sa Myelodysplastic Syndromes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Nagre-recruitPhase 2
  • Northwestern University, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
  • at 1 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2
  • Northwestern University, Chicago
  • Swedish Covenant Hospital, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06577441

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Nagre-recruitPhase 1
  • University of Chicago Comprehensive Cancer Center, Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06484062

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

Nagre-recruitPhase 3
  • University of Chicago, Duchossois Center for Advanced Medicine (DCAM), Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465953

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Nagre-recruitPhase 1/2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241

Mosaic Trial for Stem Cell Transplant Recipients

Nagre-recruit
  • Northwestern University Feinberg School of Medicine, Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06960993

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Nagre-recruitPhase 1/2
  • Northwestern University, Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT05732103

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Nagre-recruitPhase 1/2
  • Northwestern, Chicago
Edad 12 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT04988555

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Nagre-recruitPhase 1
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Edad 1 hanggang 40 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT05292664

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Nagre-recruit
  • University of Chicago Comprehensive Cancer Center, Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT05745285

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Chicago
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Nagre-recruitPhase 1
  • Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2025 · NCT06501196

Pag-aaral para sa Myelodysplastic Syndromes sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.